GRAZAX

birch pollen sublingual immunotherapy tablet · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for GRAZAX, covering 2008-09-30 to 2025-01-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Children and Adolescents With Birch Pollen-induced Rhinoconjunctivitis [Phase 3]